About Us

Direct Disease Detection

We are addressing the growing need for a comprehensive set of diagnostic information to enable the acceleration and success of drug development and enhance patient care in neurological disorders. Available technologies rely on algorithms or surrogate biomarkers to detect disease and are currently limited to proteins associated with Alzheimer’s disease. While these technologies may be able to detect proteins that pass through the blood-brain barrier, they cannot differentiate between healthy proteins and disease-specific proteins that aggregate in the brain and are associated with neurological disease.

Our technology is the first platform that has demonstrated the ability to directly detect and quantify the disease-specific proteins that aggregate in the brain and signal the presence of Alzheimer’s disease, Parkinson’s disease and other neurological disorders, as well as co-pathologies that may be present. These proteins include amyloid beta (Aβ), tau, alpha synuclein (α-synuclein), TDP43, and other protein and non-protein biomarkers.

​

This important work and our team’s unwavering commitment to achieving our goals is driven by our values. At Sunbird Bio, we are:

​

• Innovative: We are mission driven, unconventional thinkers and problem solvers, motivated by what could be.
   

• Integrous: We are committed to doing what’s right, with humility and accountability to deliver trusted results to patients in need.
   

• Resilient: We are agile and adaptable in our fast paced, dynamic world, demonstrating grit and perseverance daily.
   

• Achieving More Together: We are a diverse team, unified by open communication, collaboration, continuous learning, and respect, creating a safe and supportive environment in which we may all thrive.